Memorial Sloan-Kettering Cancer Center @ Suffolk

Commack, New York 11725

0 studies enrolling now · 94 studies all time

What they study most

Acute Promyelocytic Leukemia, Adenocarcinoma, Adenoid Cystic Carcinoma, Advanced Epithelial Ovarian, Advanced Gastrointestinal Stromal Tumor (GIST), Advanced Lung Cancer, Anal Cancer, Atrophic Vaginitis, Bladder Cancer, Brain Cancer, Brain Metastases, Breast Cancer

Studies at this site

• Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors — Running, not enrolling
• Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma — Running, not enrolling
• Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer — Running, not enrolling
• Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC) — Running, not enrolling
• Lenalidomide Maintenance in Plasma Cell Myeloma — Running, not enrolling
• Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma — Running, not enrolling
• Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver — Running, not enrolling
• Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer — Completed
• A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis — Running, not enrolling
• Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib — Running, not enrolling
• Predicting Effective Therapy in Pancreatic Cancer — Running, not enrolling
• Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy — Running, not enrolling
• Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy — Completed
• Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma — Completed
• T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) — Completed
• Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission — Running, not enrolling
• Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions — Completed
• Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer — Running, not enrolling
• MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study — Running, not enrolling
• Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen — Completed
• High Dose Carfilzomib for Newly Diagnosed Myeloma — Completed
• Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment — Running, not enrolling
• A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma — Completed
• Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma — Completed
• Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma — Completed
• Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma — Completed
• Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer — Completed
• Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis — Completed
• Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant — Completed
• Study of Romiplostim for Chemotherapy Induced Thrombocytopenia — Completed
• Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer — Completed
• Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas — Completed
• Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer — Completed
• Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Thoracic Surgery — Completed
• Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma — Completed
• Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies — Completed
• Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas — Completed
• Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies — Completed
• Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer — Completed
• Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients — Completed
• 18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain — Completed
• Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) — Completed
• Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM) — Completed
• Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC) — Completed
• Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy — Completed
• 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy — Completed
• Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC) — Completed
• Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium — Completed
• Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases — Completed
• Nintedanib in Patients With Advanced Esophagogastric Cancer — Completed